
Senior Editor at @NatureBiotech. Views are my own
London, England
Joined January 2019
- Tweets240
- Following206
- Followers461
- Likes594
Rong retweeted
Single-cell spatial pharmacobiology identifies conserved stromal barriers to therapeutic antibody delivery in human solid tumors go.nature.com/4atBJML
Rong retweeted
The dawn of in vivo immune cell engineering in oncology go.nature.com/4r732m4
Rong retweeted
On our latest podcast, Barbara Cheifet talks with Zhenan Bao and John Rogers about the latest in electronic wearables and how they will complement and advance global health — from health monitoring in neonates to smart bandages for wounds shows.acast.com/forum/episod…
Rong retweeted
🚨New podcast alert🚨
On the latest episode of Forum, Barbara Cheifet speaks with Vasilis Ntziachristos and Junjie Yao about how photoacoustic imaging is moving towards translational applications such as diagnostics and disease monitoring shows.acast.com/forum/episod…
Rong retweeted
With this cross-journal Collection, the editors at @CommsEng, @NatureBiotech, @NatureComms & @SciReports invite manuscripts that highlight continual or real-time sensing systems of any form, primarily for arable farming or crop production. Submission deadline: 21 January 2026 nature.com/collections/hdhad…
Rong retweeted
Fruit waste for catwalk fashion nature.com/articles/s41587-0…
Rong retweeted
The May issue is live nature.com/nbt/volumes/43/is…
On the cover, a platform for template-independent enzymatic synthesis of RNA oligonucleotides using reversible terminator nucleoside triphosphates that offers a sustainable alternative to traditional methods go.nature.com/3zBfDZf
Rong retweeted
A gene-editing treatment used on a 9½-month-old boy with a rare condition has the potential to help people with thousands of other uncommon genetic diseases #NBTNewsBeat nytimes.com/2025/05/15/healt…
Rong retweeted
Synergizing advances in artificial intelligence with mathematical modeling will improve our ability to computationally predict immunotherapy outcomes go.nature.com/4jfqM3Y
rdcu.be/eh1qR
Rong retweeted
The identification of novel targets together with technological advances is transforming our ability to effectively modulate the tumor microenvironment go.nature.com/42Bo9lT
rdcu.be/eiiow
Rong retweeted
The April issue is live, with a focus on cancer immunotherapy nature.com/nbt/volumes/43/is…
On the cover, recent clinical trials and patient reports have found promising outcomes of locoregional administration of CAR T cells across different solid tumors go.nature.com/3Z4eBiQ
Rong retweeted
Spotlight on cancer immunotherapies go.nature.com/3XUTPkM
Rong retweeted
A method for designing high-affinity, specific binders to peptide–MHC complexes may improve the next generation of antigen-specific T cell-based therapeutics #NBTNV go.nature.com/3ZFVH0O
rdcu.be/d3ZBW
Rong retweeted
Plant bling: cellulose that sparkles nature.com/articles/s41587-0…
Rong retweeted
In Brief: One year after partnering with Zhuhai, China–based Biotheus on a bispecific antibody targeting PD-L1 and VEGF-A, @BioNTech_Group acquires the company for up to $950 million nature.com/articles/s41587-0…
Rong retweeted
Our editors pick their favorite research articles from 2024 go.nature.com/49kVEvC
Rong retweeted
Our top ten news stories in 2024 nature.com/articles/s41587-0…
Rong retweeted
The @NobelPrize in medicine was awarded for the discovery of miRNA, but miRNA therapeutics have a long way to go before they outcompete other therapies go.nature.com/3NTD8R3
Rong retweeted
Cell-specific molecular delivery with enveloped delivery vehicles enables genome editing ex vivo and in vivo go.nature.com/47vW1Rp
rdcu.be/d0DC8
Rong retweeted
Pooled CRISPR screens with joint single-nucleus chromatin accessibility and transcriptome profiling go.nature.com/4hXER5O














